{"nct_id":"NCT02900664","title":"A Study of PDR001 in Combination With CJM112, EGF816, Ilaris® (Canakinumab) or Mekinist® (Trametinib)","status":"COMPLETED","status_verified_date":"2022-03","start_date":"2016-08-23","start_date_type":"ACTUAL","primary_completion_date":"2021-03-17","primary_completion_date_type":"ACTUAL","completion_date":"2021-03-17","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["NVS"]}